Open AccessIs adjuvant radiotherapy necessary for FIGO stage 1a grade 2 endometrial endometrioid adenocarcinoma?
Author(s) -
Abdurrahman Hamdi İnan,
Gülçı̇n Şahin Ersoy,
Yusuf Yıldırım,
Tutku Gürbüz,
Ayşe Gül Kebapçılar,
Merih Hanhan
Publication year - 2015
Publication title -
journal of the turkish-german gynecological association
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.346
H-Index - 16
eISSN - 1309-0399
pISSN - 1309-0380
DOI - 10.5152/jtgga.2015.15163
Subject(s) - medicine , radiation therapy , stage (stratigraphy) , endometrial cancer , adjuvant , distant metastasis , adjuvant radiotherapy , adenocarcinoma , survival rate , oncology , surgery , metastasis , cancer , paleontology , biology
The impact of adjuvant radiotherapy on the rates of survival and local recurrence was analyzed in patients diagnosed with International Federation of Gynecology and Obstetrics (FIGO) stage 1a grade 2 endometrial endometrioid adenocarcinoma.